We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Constellium
CSTM
$3.95B
| $5.33M | 0.03% |
309,839
-15,877
| -5% | -$244K |
|
652
BJs Wholesale Club
BJ
$11.9B
| $5.32M | 0.03% |
84,479
-25,927
| -23% | -$1.79M |
|
|
TRTN
653
DELISTED
Triton International Limited
TRTN
| $5.29M | 0.03% |
63,502
-56,010
| -47% | -$4.54M |
|
654
Boyd Gaming
BYD
$6.05B
| $5.27M | 0.02% |
+75,954
| New | +$5.1M |
|
655
Rush Enterprises Class A
RUSHA
$9.62B
| $5.26M | 0.02% |
129,782
+14,355
| +12% | +$527K |
|
656
RxSight
RXST
$292M
| $5.25M | 0.02% |
+182,155
| New | +$4.05M |
|
657
Franco-Nevada
FNV
$44.7B
| $5.22M | 0.02% |
+36,575
| New | +$5.49M |
|
|
JWN
658
DELISTED
Nordstrom
JWN
| $5.22M | 0.02% |
+254,778
| New | +$4.28M |
|
659
Kennametal
KMT
$2.32B
| $5.2M | 0.02% |
183,188
+147,291
| +410% | +$3.95M |
|
660
RPC Inc
RES
$1.39B
| $5.18M | 0.02% |
724,364
+617,552
| +578% | +$4.52M |
|
661
Transmedics
TMDX
$3.11B
| $5.18M | 0.02% |
61,666
-67,922
| -52% | -$5.2M |
|
662
Idexx Laboratories
IDXX
$44.7B
| $5.18M | 0.02% |
10,309
+8,403
| +441% | +$4.03M |
|
663
Global Payments
GPN
$25.1B
| $5.17M | 0.02% |
+52,474
| New | +$5.4M |
|
|
DO
664
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $5.15M | 0.02% |
361,889
-12,036
| -3% | -$142K |
|
665
Appian
APPN
$2.65B
| $5.09M | 0.02% |
106,893
-27,995
| -21% | -$1.18M |
|
|
DEN
666
DELISTED
Denbury Inc.
DEN
| $5.09M | 0.02% |
58,982
-143,225
| -71% | -$13M |
|
667
Sumitomo Mitsui Financial
SMFG
$167B
| $5.07M | 0.02% |
589,576
-259,262
| -31% | -$2.14M |
|
668
FormFactor
FORM
$10.3B
| $5.05M | 0.02% |
147,648
+5,839
| +4% | +$174K |
|
669
Under Armour Class C
UA
$2.25B
| $5.05M | 0.02% |
752,884
-383,829
| -34% | -$2.82M |
|
|
SWTX
670
DELISTED
SpringWorks Therapeutics
SWTX
| $5.04M | 0.02% |
192,250
-158,544
| -45% | -$4.17M |
|
671
Manhattan Associates
MANH
$11.7B
| $5.04M | 0.02% |
25,213
+6,849
| +37% | +$1.19M |
|
672
Alexandria Real Estate Equities
ARE
$8.33B
| $5M | 0.02% |
44,100
-3,099
| -7% | -$369K |
|
673
VICI Properties
VICI
$29B
| $4.99M | 0.02% |
158,836
-645,003
| -80% | -$20.7M |
|
674
Kymera Therapeutics
KYMR
$9.51B
| $4.95M | 0.02% |
215,207
-36,154
| -14% | -$1.04M |
|
675
CRH
CRH
$65B
| $4.94M | 0.02% |
88,613
+55,267
| +166% | +$2.76M |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.